Skip to content

The Effect of Tendon Release Techniques in Patients With Cervical Disc Herniation

The Effect of Improved Golgi Tendon Organ Stimulation From Tendon Relaxation Techniques on Pain, Range of Motion, Functionality, Endurance and Quality of Life in Patients With Cervical Disc Herniation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06526325
Enrollment
51
Registered
2024-07-29
Start date
2024-02-19
Completion date
2024-08-19
Last updated
2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Disc Herniation

Keywords

disc herniation, enhanced golgi tendon organ stimulation, pain, cervical

Brief summary

The goal of this clinical trial is to investigate the effect of using enhanced golgi tendon organ stimulation on symptoms in patients with cervical disc herniation. The main question\[s\] it aims to answer are: * Enhanced Golgi tendon organ stimulation is effective in reducing symptoms in patients with cervical disc herniation. * Enhanced golgi tendon organ stimulation is not effective in reducing symptoms in patients with cervical disc herniation. Participants will receive enhanced golgi tendon organ stimulation to the Sternocleidomastoideus, platysma, longus colli, longus capitis, scalene, rhomboid major & minor, levator scapulae and trapezius muscles for 3 weeks, 2 sessions per week for 45 minutes.

Detailed description

Participants diagnosed with cervical disc herniation will be included. Participants will receive 6 sessions of 45 minutes each, 2 sessions per week for 3 weeks. Sternocleidomastoideus, platysma, longus colli, longus capitis, scalene muscles, rhomboid major & minor, levator scapulae and trapezius muscles and tendons of these muscles will be applied. Two separate applications are performed with the stimulator and the algometer. After increasing the blood flow in the area for 30 seconds with the vibration of the stimulator up to the point of attachment of the tendon, a pressure of 0.5 kilograms is applied at an angle of 90 degrees at 0.5 cm intervals from the origin to the insertion of the muscle in the area with an algometer made of special steel. The aim of this treatment is to stabilise the contraction and relaxation mechanism by stimulating the Golgi tendon organ and to eliminate pain by relieving spasms.

Interventions

DEVICEEnhanced golgi tendon organ stimulation

Enhanced Golgi Tendon Organ Stimulation is a method that can be used by physiotherapists and doctors. The Golgi tendon organ is the proprioceptors located in the tendon adjacent to the myotendinous junction. It is applied using two separate heads, the stimulator and the algometer. The sternocleidomastoideus, platysma, colli longus, capitis longus, scalene, rhomboid major and minor, levator scapulae and trapezius muscles and their tendons will be vibrated with a stimulator for 30 seconds, then 0.5 kilograms of pressure will be applied with an algometer from the origin to the insertion of the muscle in the region at 0.5 centimetre intervals at an angle of 90 degrees.

Sponsors

Istanbul Arel University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being diagnosed with cervical disc herniation * Volunteering for the research

Exclusion criteria

* Chronic bone disease * Have had surgery for a cervical disc herniation * Have a structural abnormality

Design outcomes

Primary

MeasureTime frameDescription
Pain assessment with algometerbaseline, immediately after the 6 weeks interventionThe sternocleidomastoid, platysma, longus colli, longus capitis, scalene, rhomboid major and minor, levator scapulae and trapezius muscles and their tendons are compressed to 0.5 kg using an algometer. The patient's response is used to determine whether or not there is pain.
SF-36 (short form-36)baseline, immediately after the 6 weeks interventionThe Short Form-36 (SF-36) is a self-assessment scale and analyses 8 dimensions of health including physical function, social function, role limitations (due to physical and emotional reasons), mental health, vitality (energy), pain and general perception of health with 36 items. In scoring the scale, each sub-dimension is given a score between 0 and 100 points, where 0 points indicate that the quality of life dimension is poor and 100 points indicate that it is good.

Secondary

MeasureTime frameDescription
visual analogue scale (VAS)baseline, immediately after the 6 weeks interventionFor pain intensity according to VAS, no pain is usually graded as 0 points and worst imaginable pain as 10 points (10 cm scale). The ranges for pain intensity are \<3 mild pain, 3-6 moderate pain, \>6 severe pain.
assessment of joint range of motionbaseline, immediately after the 6 weeks interventionRange of motion of the cervical spine will be assessed with a goniometer.
Spurling Testbaseline, immediately after the 6 weeks interventionWith the patient in an upright sitting position, the clinician flexes and laterally flexes the patient's head and applies cranial to caudal compression. The test is considered positive if there is pain, numbness and tingling. A positive spurling test indicates that there may be a problem such as a possible nerve root compression in this area. If the test is negative, it is said that nerve root compression is less likely.
Endurance Testbaseline, immediately after the 6 weeks interventionThe patient performs flexion, extension, right lateral flexion, left lateral flexion, right rotation and left rotation. Meanwhile, the clinician maintains the position by applying the same force in the opposite direction of movement. A stopwatch is used to time the onset of pain. The longer the time, the better the outcome. A shorter time indicates a poor clinical prognosis.

Countries

Turkey (Türkiye)

Contacts

Primary Contacthasan aslan
asfizyoterapi@gmail.com+905538073527
Backup Contactmehmet aslan
sharisin.aslan@gmail.com+905521873527

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026